KU124 (9,10,10-trioxo-N-(2-phenylphenyl)thioxanthene-3-carboxamide) as a novel inhibitor of TASK-1

TASK-1 is a two-pore K+ leak channel. The name, TASK-1, stands for TWIK-related acid-sensitive potassium channel 1, and this channel is encoded by the KCNK3 gene. TASK-1 channels are expressed in humans and modulate cell excitability in excitable cells such as neurons, cardiomyocytes, and vascular s...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Dumani, Annette Jacob, Diego Chavez, Abena Amankwaa, Ramish Zahed, Martha Julemis, Hinaben Patel, Joana Lopez, Steven Almazan, Patrick Martins, Anthony Contreras, Sofiia Korotka, Gianna Kiszka, Alexander Aleynik, Justin Patino, David Graham, Megan Blaisdell, Youssef Elhowary, Shuayb Yousuf, Chelsea Pelley, Jenna Marciano, Jessica Best, Rhustie Valdizno, Nikki Mastrodomenico, Jonelle Brown, Sarah Schwartz, Irene Anin, Yara Farrag, Rinchu George, Gianna Medeiros, Sophia Lang, Marilyn Dennis, Oluwatoni Awoleye, Lamont Lee, Ericka Salgado, Diana Figueroa Chea, Thomas Walter Comollo
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1577171/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849683066258194432
author Ana Dumani
Annette Jacob
Diego Chavez
Abena Amankwaa
Ramish Zahed
Martha Julemis
Hinaben Patel
Joana Lopez
Steven Almazan
Patrick Martins
Anthony Contreras
Sofiia Korotka
Gianna Kiszka
Alexander Aleynik
Justin Patino
David Graham
Megan Blaisdell
Youssef Elhowary
Shuayb Yousuf
Chelsea Pelley
Jenna Marciano
Jessica Best
Rhustie Valdizno
Nikki Mastrodomenico
Jonelle Brown
Sarah Schwartz
Irene Anin
Yara Farrag
Rinchu George
Gianna Medeiros
Sophia Lang
Marilyn Dennis
Oluwatoni Awoleye
Lamont Lee
Ericka Salgado
Diana Figueroa Chea
Thomas Walter Comollo
Thomas Walter Comollo
author_facet Ana Dumani
Annette Jacob
Diego Chavez
Abena Amankwaa
Ramish Zahed
Martha Julemis
Hinaben Patel
Joana Lopez
Steven Almazan
Patrick Martins
Anthony Contreras
Sofiia Korotka
Gianna Kiszka
Alexander Aleynik
Justin Patino
David Graham
Megan Blaisdell
Youssef Elhowary
Shuayb Yousuf
Chelsea Pelley
Jenna Marciano
Jessica Best
Rhustie Valdizno
Nikki Mastrodomenico
Jonelle Brown
Sarah Schwartz
Irene Anin
Yara Farrag
Rinchu George
Gianna Medeiros
Sophia Lang
Marilyn Dennis
Oluwatoni Awoleye
Lamont Lee
Ericka Salgado
Diana Figueroa Chea
Thomas Walter Comollo
Thomas Walter Comollo
author_sort Ana Dumani
collection DOAJ
description TASK-1 is a two-pore K+ leak channel. The name, TASK-1, stands for TWIK-related acid-sensitive potassium channel 1, and this channel is encoded by the KCNK3 gene. TASK-1 channels are expressed in humans and modulate cell excitability in excitable cells such as neurons, cardiomyocytes, and vascular smooth muscle cells. TASK-1 inhibition is a mechanism of action for some respiratory stimulants, such as doxapram. TASK-1 channels have also been suggested to play a role in circumventing cell apoptosis in a population of non-small-cell lung cancer cells. We propose that the inner vestibule of the TASK-1 channel, a known binding site of known TASK-1 inhibitors, BAY10000493 and BAY2341237, can be exploited via virtual screening to find other novel TASK-1 inhibitors. Our results show that by targeting the inner vestibule site, we found an active TASK-1 inhibitor. We suspect that this region of interest can be further exploited to discover additional TASK-1 inhibitors. Our initial success lends validity to our virtual screening methodology and parameters. In this study, we identified a novel TASK-1 inhibitor, KU124, which we verified using an in vitro assay.
format Article
id doaj-art-ffc0224f5e504d5caad5b95675ad4e46
institution DOAJ
issn 1663-9812
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-ffc0224f5e504d5caad5b95675ad4e462025-08-20T03:24:01ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-06-011610.3389/fphar.2025.15771711577171KU124 (9,10,10-trioxo-N-(2-phenylphenyl)thioxanthene-3-carboxamide) as a novel inhibitor of TASK-1Ana Dumani0Annette Jacob1Diego Chavez2Abena Amankwaa3Ramish Zahed4Martha Julemis5Hinaben Patel6Joana Lopez7Steven Almazan8Patrick Martins9Anthony Contreras10Sofiia Korotka11Gianna Kiszka12Alexander Aleynik13Justin Patino14David Graham15Megan Blaisdell16Youssef Elhowary17Shuayb Yousuf18Chelsea Pelley19Jenna Marciano20Jessica Best21Rhustie Valdizno22Nikki Mastrodomenico23Jonelle Brown24Sarah Schwartz25Irene Anin26Yara Farrag27Rinchu George28Gianna Medeiros29Sophia Lang30Marilyn Dennis31Oluwatoni Awoleye32Lamont Lee33Ericka Salgado34Diana Figueroa Chea35Thomas Walter Comollo36Thomas Walter Comollo37Kean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesTouro University, New York, NY, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesKean University, Union, NJ, United StatesTouro University, New York, NY, United StatesTASK-1 is a two-pore K+ leak channel. The name, TASK-1, stands for TWIK-related acid-sensitive potassium channel 1, and this channel is encoded by the KCNK3 gene. TASK-1 channels are expressed in humans and modulate cell excitability in excitable cells such as neurons, cardiomyocytes, and vascular smooth muscle cells. TASK-1 inhibition is a mechanism of action for some respiratory stimulants, such as doxapram. TASK-1 channels have also been suggested to play a role in circumventing cell apoptosis in a population of non-small-cell lung cancer cells. We propose that the inner vestibule of the TASK-1 channel, a known binding site of known TASK-1 inhibitors, BAY10000493 and BAY2341237, can be exploited via virtual screening to find other novel TASK-1 inhibitors. Our results show that by targeting the inner vestibule site, we found an active TASK-1 inhibitor. We suspect that this region of interest can be further exploited to discover additional TASK-1 inhibitors. Our initial success lends validity to our virtual screening methodology and parameters. In this study, we identified a novel TASK-1 inhibitor, KU124, which we verified using an in vitro assay.https://www.frontiersin.org/articles/10.3389/fphar.2025.1577171/fullTWIK-related acid-sensitive potassium channel 1virtual screeninginhibitorKU124molecular dynamicsthallium flux
spellingShingle Ana Dumani
Annette Jacob
Diego Chavez
Abena Amankwaa
Ramish Zahed
Martha Julemis
Hinaben Patel
Joana Lopez
Steven Almazan
Patrick Martins
Anthony Contreras
Sofiia Korotka
Gianna Kiszka
Alexander Aleynik
Justin Patino
David Graham
Megan Blaisdell
Youssef Elhowary
Shuayb Yousuf
Chelsea Pelley
Jenna Marciano
Jessica Best
Rhustie Valdizno
Nikki Mastrodomenico
Jonelle Brown
Sarah Schwartz
Irene Anin
Yara Farrag
Rinchu George
Gianna Medeiros
Sophia Lang
Marilyn Dennis
Oluwatoni Awoleye
Lamont Lee
Ericka Salgado
Diana Figueroa Chea
Thomas Walter Comollo
Thomas Walter Comollo
KU124 (9,10,10-trioxo-N-(2-phenylphenyl)thioxanthene-3-carboxamide) as a novel inhibitor of TASK-1
Frontiers in Pharmacology
TWIK-related acid-sensitive potassium channel 1
virtual screening
inhibitor
KU124
molecular dynamics
thallium flux
title KU124 (9,10,10-trioxo-N-(2-phenylphenyl)thioxanthene-3-carboxamide) as a novel inhibitor of TASK-1
title_full KU124 (9,10,10-trioxo-N-(2-phenylphenyl)thioxanthene-3-carboxamide) as a novel inhibitor of TASK-1
title_fullStr KU124 (9,10,10-trioxo-N-(2-phenylphenyl)thioxanthene-3-carboxamide) as a novel inhibitor of TASK-1
title_full_unstemmed KU124 (9,10,10-trioxo-N-(2-phenylphenyl)thioxanthene-3-carboxamide) as a novel inhibitor of TASK-1
title_short KU124 (9,10,10-trioxo-N-(2-phenylphenyl)thioxanthene-3-carboxamide) as a novel inhibitor of TASK-1
title_sort ku124 9 10 10 trioxo n 2 phenylphenyl thioxanthene 3 carboxamide as a novel inhibitor of task 1
topic TWIK-related acid-sensitive potassium channel 1
virtual screening
inhibitor
KU124
molecular dynamics
thallium flux
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1577171/full
work_keys_str_mv AT anadumani ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT annettejacob ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT diegochavez ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT abenaamankwaa ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT ramishzahed ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT marthajulemis ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT hinabenpatel ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT joanalopez ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT stevenalmazan ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT patrickmartins ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT anthonycontreras ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT sofiiakorotka ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT giannakiszka ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT alexanderaleynik ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT justinpatino ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT davidgraham ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT meganblaisdell ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT youssefelhowary ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT shuaybyousuf ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT chelseapelley ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT jennamarciano ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT jessicabest ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT rhustievaldizno ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT nikkimastrodomenico ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT jonellebrown ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT sarahschwartz ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT ireneanin ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT yarafarrag ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT rinchugeorge ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT giannamedeiros ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT sophialang ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT marilyndennis ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT oluwatoniawoleye ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT lamontlee ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT erickasalgado ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT dianafigueroachea ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT thomaswaltercomollo ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1
AT thomaswaltercomollo ku12491010trioxon2phenylphenylthioxanthene3carboxamideasanovelinhibitoroftask1